News

ELCC: PD-L1 expression and association with survival in mesothelioma

31 Mar 2014
ELCC: PD-L1 expression and association with survival in mesothelioma

Therapeutic targeting implications may arise.

Data from the Mayo Clinic, Rochester, USA, shows that a programmed cell death 1 ligand 1 (PD-L1) is expressed in a substantial number of cases with malignant pleural mesothelioma.

To read the rest of this story visit the ESMO site.